CTRI/2021/04/033076已完成4 期
An Open Label, Multicentre, Post-Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Desvenlafaxine Succinate Equivalent to Desvenlafaxine 100mg/50mg and Clonazepam 0.5 mg/0.5mg uncoated bilayered tablet in Major Depressive Disorder with Co-Morbid Anxiety
GKM New Pharma0 个研究点目标入组 200 人开始时间: 待定最近更新:
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 200
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Pms
入排标准
入选标准
- •1. Willing and able to sign informed consent form.
- •2. Male and female patients of aged 18 years to 75 years with a primary diagnosis of MDD.
- •3. Patients prescribed with medication for co-morbid depression and anxiety.
- •4. Female patient of child-bearing age on medically acceptable contradiction, including oral contraceptives, injectable or implantable methods, intrauterine devices or properly used barrier contraception
排除标准
- •1. Patients on selective Serotonin Reuptake Inhibitor drugs (SSRI) and Monoamine oxidase inhibitors (MAOIs) 90 days prior to screening
- •2. Clinically important abnormalities on screening, physical examinations, or use of prohibited treatments.
- •3. Any other condition as per investigatorââ?¬•s discretion.
- •4. Currently participating (or participated within the previous 30 days) in an investigational therapeutic or device study.
- •5. Female who is pregnant, nursing, or of child-bearing potential.
研究者
相似试验
已完成
4 期
Post-Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Escitalopram 5 mg/10 mg and Etizolam 0.5 mg in Subjects with Major Depressive Disorder with Associated AnxietyCTRI/2020/08/026974Macsur Pharmaa I Pvt Ltd200
已完成
4 期
A study to evaluate the safety and effect of Ropin Heavy® injection for spinal anaesthesia in adult subjectsCTRI/2022/03/040917eon Laboratories Ltd
招募中
4 期
A study of stempeucel® in patients with critical limb ischemia due to occlusive inflammatory condition of arteries and veinsCTRI/2018/02/011839Stempeutics Research Pvt Ltd
已完成
4 期
An Open Label, Multicentre Post-Marketing Surveillance study to Monitor the Safety and Efficacy of Combination Therapy of Amitriptyline 12.5mg/25mg and Chlordiazepoxide 5mg/10mg in Subjects with Major Depressive Disorder with Associated Anxiety in Regular PracticeCTRI/2020/07/026583Macsur Pharmaa I Pvt Ltd200
已完成
4 期
This is a postmarketing surveillance to determine the efficacy and safety of 0.05 % Cyclosporine ophthalmic micro-emulsion for the treatment of Moderate to Severe Dry eye diseaseCTRI/2010/091/000095Cipla Ltd36